Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

175 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ST segment elevation myocardial infarction (STEMI) patients are more likely to achieve lipid-lowering treatment goals: A retrospective analysis of patients presenting with first acute coronary syndromes.
Güntekin Ü, Tosun V, Kilinç AY, Saydam G, Korucuk N, Bozdemir MN. Güntekin Ü, et al. Among authors: saydam g. Medicine (Baltimore). 2018 Sep;97(39):e12225. doi: 10.1097/MD.0000000000012225. Medicine (Baltimore). 2018. PMID: 30278492 Free PMC article.
Treatment Patterns and Clinical Outcomes in Patients with Hodgkin Lymphoma from Saudi Arabia, Türkiye, and South Africa: Subgroup Analysis from the International Multicenter Retrospective B-HOLISTIC Study.
Brittain D, Akhtar S, Rodrigues S, Patel M, Moodley D, Singh JP, Dreosti LM, Mohamed Z, Al-Mansour M, Alzahrani M, Rauf MS, Maghfoor I, Kalayoğlu Beşışık S, Boğa C, Saydam G, Huang Z, Pinchevsky Y, Ferhanoğlu B. Brittain D, et al. Among authors: saydam g. Turk J Haematol. 2024 Dec 2;41(4):211-224. doi: 10.4274/tjh.galenos.2024.2024.0181. Epub 2024 Oct 28. Turk J Haematol. 2024. PMID: 39463021 Free PMC article.
A new scoring system to predict survival in elderly advanced stage Hodgkin lymphoma patients.
Mehtap Ö, Toptas T, Dal MS, Karadag FK, Atas U, Özsan GH, Sayınalp N, Saydam G, Uçar MA, Kırkızlar HO, Salim O, Tekinalp A, Özkalemkaş F, Pepedi F, Akay OM, Kılıçaslan E, Paydas S, Bozdağ SC, Yılmaz M, Karakus V, Arikan FG, Darçın T, Erdogan E, Cinar E, Gürsoy V, Durusoy SS, Birtaş Ateşoğlu E, Tombak A, Büyükkurt N, Özcan M, Altuntaş F, Kaygusuz Atagündüz I, Ferhanoglu B. Mehtap Ö, et al. Among authors: saydam g. Leuk Lymphoma. 2024 Dec;65(14):2190-2198. doi: 10.1080/10428194.2024.2395458. Epub 2024 Sep 13. Leuk Lymphoma. 2024. PMID: 39269267
The assessment of health-related quality of life in patients with polycythemia vera.
Doğan EE, Keklik Karadağ F, Aydin D, Demirel N, Sağlam S, Davulcu EA, Turan Erkek E, Eren R, Akad Soyer N, Şahin F, Saydam G. Doğan EE, et al. Among authors: saydam g. Medicine (Baltimore). 2024 Jul 26;103(30):e38814. doi: 10.1097/MD.0000000000038814. Medicine (Baltimore). 2024. PMID: 39058813 Free PMC article.
Belantamab Mafodotin, Pomalidomide, and Dexamethasone in Multiple Myeloma.
Dimopoulos MA, Beksac M, Pour L, Delimpasi S, Vorobyev V, Quach H, Spicka I, Radocha J, Robak P, Kim K, Cavo M, Suzuki K, Morris K, Pompilus F, Phillips-Jones A, Zhou XL, Fulci G, Sule N, Kremer BE, Opalinska J, Mateos MV, Trudel S; DREAMM-8 Investigators. Dimopoulos MA, et al. N Engl J Med. 2024 Aug 1;391(5):408-421. doi: 10.1056/NEJMoa2403407. Epub 2024 Jun 2. N Engl J Med. 2024. PMID: 38828951 Clinical Trial.
Single agent vemurafenib or rituximab-vemurafenib combination for the treatment of relapsed/refractory hairy cell leukemia, a multicenter experience.
Yiğit Kaya S, Mutlu YG, Malkan ÜY, Mehtap Ö, Keklik Karadağ F, Korkmaz G, Elverdi T, Saydam G, Özet G, Ar MC, Melek E, Maral S, Kaynar L, Sevindik ÖG. Yiğit Kaya S, et al. Among authors: saydam g. Leuk Res. 2024 May;140:107495. doi: 10.1016/j.leukres.2024.107495. Epub 2024 Mar 29. Leuk Res. 2024. PMID: 38599153
Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma.
Sonneveld P, Dimopoulos MA, Boccadoro M, Quach H, Ho PJ, Beksac M, Hulin C, Antonioli E, Leleu X, Mangiacavalli S, Perrot A, Cavo M, Belotti A, Broijl A, Gay F, Mina R, Nijhof IS, van de Donk NWCJ, Katodritou E, Schjesvold F, Sureda Balari A, Rosiñol L, Delforge M, Roeloffzen W, Silzle T, Vangsted A, Einsele H, Spencer A, Hajek R, Jurczyszyn A, Lonergan S, Ahmadi T, Liu Y, Wang J, Vieyra D, van Brummelen EMJ, Vanquickelberghe V, Sitthi-Amorn A, de Boer CJ, Carson R, Rodriguez-Otero P, Bladé J, Moreau P; PERSEUS Trial Investigators. Sonneveld P, et al. N Engl J Med. 2024 Jan 25;390(4):301-313. doi: 10.1056/NEJMoa2312054. Epub 2023 Dec 12. N Engl J Med. 2024. PMID: 38084760 Clinical Trial.
175 results